Cite

HARVARD Citation

    Shirahama, T. et al. (2017). A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer. Cancer science. 108 (5), pp. 838-845. [Online]. 
  
Back to record